CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation-Reference-Cited by-同舟云学术

CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation

Published:2021-01-02 Issue:1 Volume:53 Page:30-44
ISSN:0360-2532
Container-title:Drug Metabolism Reviews
language:en
Short-container-title:Drug Metabolism Reviews

Author:

Barrangou-Poueys-Darlas Malcolm¹^ORCID,Guerlais Marylène¹,Laforgue Edouard-Jules¹²³,Bellouard Ronan¹,Istvan Marion¹,Chauvin Pascale⁴,Guillet Jean-Yves⁴,Jolliet Pascale¹³,Gregoire Matthieu¹⁵^ORCID,Victorri-Vigneau Caroline¹³

Affiliation:

1. Clinical Pharmacology Department, University Hospital Centre Nantes, Nantes, France

2. Addictology and Psychiatry Department, University Hospital Centre Nantes, Nantes, France

3. INSERM UMR 1246 SPHERE (methodS in Patients-centered outcomes and HEalth Research), Nantes and Tours Universities, Nantes, France

4. Addictology Regional Network (URAA), Structure Régionale d’Appui et d’Expertise Addictologie des Pays de la Loire, Nantes, France

5. INSERM UMR 1235 The Enteric Nervous System in Gut and Brain Disorders, University of Nantes, Nantes, France

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.tandfonline.com/doi/pdf/10.1080/03602532.2020.1859528

Reference27 articles.

1. Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products

2. Olanzapine-induced parkinsonism associated with smoking cessation

3. Bleyzac N, Bourguignon L, Goutelle S, Tod M. 2015. DDI-predictor. [accessed 2020 Jan–Apr]. https://www.ddi-predictor.org/.

4. Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders

5. Clozapine Toxicity Associated with Smoking Cessation

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice;Journal of Clinical Psychopharmacology;2023-11

2. Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia;Therapeutic Advances in Psychopharmacology;2023-01

3. Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: A role of heme oxygenase 1;Chemico-Biological Interactions;2022-09

4. Adverse Drug Reactions of Olanzapine, Clozapine and Loxapine in Children and Youth: A Systematic Pharmacogenetic Review;Pharmaceuticals;2022-06-14

5. Rasagiline Pharmacokinetics in CYP1A2 Variant Healthy Smokers & Non-smokers in Different Doses;Pakistan Journal of Medical Sciences;2022-01-19